Columbia Trust Co 01012016 lifted its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 1.7% in the 3rd quarter, HoldingsChannel.com reports. The firm owned 4,583 shares of the healthcare conglomerate’s stock after acquiring an additional 75 shares during the period. UnitedHealth Group comprises about 0.9% of Columbia Trust Co 01012016’s holdings, making the stock its 26th biggest position. Columbia Trust Co 01012016’s holdings in UnitedHealth Group were worth $1,791,000 at the end of the most recent reporting period.
Other institutional investors also recently made changes to their positions in the company. Anfield Capital Management LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $26,000. RPg Family Wealth Advisory LLC purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $26,000. Mitsubishi UFJ Morgan Stanley Securities Co. Ltd. purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $28,000. Activest Wealth Management purchased a new position in shares of UnitedHealth Group in the 2nd quarter valued at approximately $29,000. Finally, Ten Capital Wealth Advisors LLC raised its position in UnitedHealth Group by 111.6% during the 2nd quarter. Ten Capital Wealth Advisors LLC now owns 91 shares of the healthcare conglomerate’s stock worth $36,000 after buying an additional 48 shares during the last quarter. 86.20% of the stock is owned by hedge funds and other institutional investors.
Shares of UNH opened at $450.16 on Thursday. UnitedHealth Group Incorporated has a 52-week low of $320.35 and a 52-week high of $466.00. The company has a quick ratio of 0.77, a current ratio of 0.77 and a debt-to-equity ratio of 0.59. The firm’s fifty day moving average is $430.47 and its two-hundred day moving average is $418.01. The stock has a market cap of $423.98 billion, a PE ratio of 27.93, a price-to-earnings-growth ratio of 1.75 and a beta of 0.85.
The firm also recently announced a quarterly dividend, which will be paid on Tuesday, December 14th. Shareholders of record on Monday, December 6th will be paid a dividend of $1.45 per share. The ex-dividend date is Friday, December 3rd. This represents a $5.80 annualized dividend and a yield of 1.29%. UnitedHealth Group’s dividend payout ratio (DPR) is presently 35.98%.
A number of equities analysts have issued reports on the stock. Mizuho raised their price target on shares of UnitedHealth Group from $455.00 to $500.00 and gave the stock a “buy” rating in a research report on Wednesday, November 10th. Cowen assumed coverage on shares of UnitedHealth Group in a research report on Thursday, September 9th. They set an “outperform” rating and a $478.00 price target for the company. Zacks Investment Research raised shares of UnitedHealth Group from a “hold” rating to a “buy” rating and set a $477.00 price target for the company in a research report on Wednesday, October 27th. BMO Capital Markets raised their price target on shares of UnitedHealth Group from $435.00 to $475.00 and gave the stock a “market perform” rating in a research report on Monday, October 18th. Finally, Evercore ISI lifted their target price on shares of UnitedHealth Group from $360.00 to $480.00 and gave the company an “outperform” rating in a report on Friday, October 15th. One research analyst has rated the stock with a hold rating, twenty-one have issued a buy rating and one has given a strong buy rating to the company. According to MarketBeat, UnitedHealth Group has a consensus rating of “Buy” and a consensus target price of $477.35.
In related news, Director Stephen J. Hemsley sold 75,000 shares of the business’s stock in a transaction dated Monday, October 25th. The shares were sold at an average price of $448.72, for a total value of $33,654,000.00. The sale was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, Director Richard T. Burke sold 2,500 shares of the business’s stock in a transaction dated Tuesday, September 14th. The shares were sold at an average price of $416.75, for a total transaction of $1,041,875.00. Following the completion of the sale, the director now owns 154,403 shares in the company, valued at $64,347,450.25. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 82,500 shares of company stock worth $36,855,125. 0.55% of the stock is currently owned by corporate insiders.
UnitedHealth Group Profile
UnitedHealth Group, Inc engages in the provision of health care coverage, software, and data consultancy services. It operates through the following segments: UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx. The UnitedHealthcare segment utilizes Optum’s capabilities to help coordinate patient care, improve affordability of medical care, analyze cost trends, manage pharmacy benefits, work with care providers more effectively, and create a simpler consumer experience.
Read More: Stock Selection – What is cash flow?
Want to see what other hedge funds are holding UNH? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for UnitedHealth Group Incorporated (NYSE:UNH).
Receive News & Ratings for UnitedHealth Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for UnitedHealth Group and related companies with MarketBeat.com's FREE daily email newsletter.